Sign In
Buy OLK
$26.08
+0 (+0%)
At Close: Oct 08, 2024
Olink reports fourth quarter and full year 2023 financial results
08:00am, Monday, 25'th Mar 2024
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023.
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
08:00am, Friday, 15'th Mar 2024
UPPSALA, Sweden, March 15, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual G
Olink announces change of date for Annual General Meeting
08:00am, Friday, 08'th Mar 2024
UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink's 2024 Annual General Meeting (“AGM”) will be held in Uppsala, S
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
09:30am, Saturday, 30'th Dec 2023
Quantum-Si has a ton of promise if the proteomics market continues to develop. Thermo Fisher indicated the future potential with its big pending acquisition of Olink.
Olink reports third quarter 2023 financial results
07:00am, Wednesday, 15'th Nov 2023
UPPSALA, Sweden, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023.
Why Earnings Season Could Be Great for Olink (OLK)
11:16am, Wednesday, 08'th Nov 2023
Olink (OLK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olink Holdin
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
05:20am, Friday, 03'rd Nov 2023
Structure Therapeutics' weight-loss drug candidate is attracting attention over excitement about obesity treatments. ImmunityBio rallied on hopes that its bladder cancer drug will now be better unders
Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for
11:19am, Thursday, 02'nd Nov 2023
Olink Holding AB (publ) Sponsored ADR (OLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink
08:43am, Tuesday, 31'st Oct 2023
WALTHAM, Mass. & UPPSALA, Sweden--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasd
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olink Holdin
Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength?
11:19am, Wednesday, 18'th Oct 2023
Olink Holding AB (publ) Sponsored ADR (OLK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving
Olink Holding stock soars on acquisition by Thermo Fisher Scientific
11:46am, Tuesday, 17'th Oct 2023
Olink Holding AB shares surged 66% to $24.87 in late-morning trading on Tuesday after the provider of next-generation proteomics solutions announced that it has agreed to be acquired by Thermo Fisher
Why Olink Stock Is Skyrocketing Today
11:29am, Tuesday, 17'th Oct 2023
Thermo Fisher Scientific plans to acquire Olink for $3.1 billion. The deal would add Olink's proteomics technology to Thermo Fisher's life sciences solutions.
